A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT05077423 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to business priorities

Conditions

AML, Childhood

Interventions

DRUG: CD33*CD3 BsAb

Sponsor

Y-mAbs Therapeutics

Collaborators

[object Object]